Practice materials

Our online library of practice materials offers downloadable resources, including patient profiles, details about clinical data, and forms for your staff.

Information and data about MIEBO

Image of MIEBO Patient Profiles PDF Image of MIEBO Patient Profiles PDF
MIEBO Patient Profiles

This series of 3 profiles spans both the ophthalmology and optometry specialties to represent patient types you may see in practice. They can help you evaluate whether MIEBO may be an appropriate treatment option.

Image of KALAHARI Flashcard Image of KALAHARI Flashcard
KALAHARI Flashcard

This flashcard summarizes the outcomes of the 52-week KALAHARI study, an analysis of the long-term safety and efficacy of MIEBO.

Image of Science Behind MIEBO Flashcard Image of Science Behind MIEBO Flashcard
Science Behind MIEBO Flashcard

This flashcard dives deeper into the MIEBO molecule and provides data on evaporation rates and precorneal residence time.

Image of In Vitro Flashcard Image of In Vitro Flashcard
In Vitro Evaporation Flashcard

This flashcard provides results from an in vitro study evaluating evaporation rates with MIEBO.

Image of MIEBO Prior Authorization (PA) Checklist Image of MIEBO Prior Authorization (PA) Checklist
Clinical Data Deep Dive Whitepaper

This whitepaper explores clinical findings from the KALAHARI, GOBI, and MOJAVE studies in a comprehensive data summary, including key trial designs, endpoints, and results.

BlinkRx ECP Leave Behind BlinkRx ECP Leave Behind
BlinkRx ECP Leave Behind

Learn how to prescribe through BlinkRx and explore a brief overview of how BlinkRx can help patients with their MIEBO prescriptions.

Patient forms

Image of MIEBO Prior Authorization (PA) Checklist Image of MIEBO Prior Authorization (PA) Checklist
MIEBO Prior Authorization (PA) Checklist

This guide can help you complete a PA request for MIEBO and ensure necessary information is provided to the payer. It also includes a list of diagnosis code examples.

MIEBO Pharmacy Flashcard MIEBO Pharmacy Flashcard
MIEBO Pharmacy Flashcard

This flashcard provides a brief overview of the product characteristics, dosing instructions, and storage information for MIEBO.

Image of BlinkRx Patient Instruction Tearpad Image of BlinkRx Patient Instruction Tearpad
BlinkRx Patient Instruction Tearpad (Commercial and Government)

These resources inform patients about BlinkRx and what to expect when you send your patient prescriptions through this program. There are 2 versions: one for commercial patients under 65 and one for government patients (including those covered by Medicare Part D).

Image of BlinkRx Fax Form Image of BlinkRx Fax Form
BlinkRx Fax Form

This form is used to e-prescribe MIEBO to BlinkRx. For more details, see BlinkRx information above.

 
 
*Required fields.

By submitting your information, you consent to receive communications containing information and educational resources about MIEBO, as well as other communications from Bausch + Lomb. By submitting your information, you confirm that you have read and agree with the terms of our Privacy Policy and Legal Notice.

INDICATION

MIEBO® (perfluorohexyloctane ophthalmic solution) is indicated for the treatment of the signs and symptoms of dry eye disease.

IMPORTANT SAFETY INFORMATION

  • MIEBO should not be administered while wearing contact lenses. Contact lenses should be removed before use and for at least 30 minutes after administration of MIEBO
  • Instruct patients to instill one drop of MIEBO into each eye four times daily
  • The safety and efficacy in pediatric patients below the age of 18 have not been established
  • The most common ocular adverse reaction was blurred vision (1% to 3% of patients reported blurred vision and conjunctival redness)

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Click here for full Prescribing Information for MIEBO.

Expand Expand Expand Expand

INDICATION AND IMPORTANT
SAFETY INFORMATION

INDICATION

MIEBO® (perfluorohexyloctane ophthalmic solution) is indicated for the treatment of the signs and symptoms of dry eye disease.

IMPORTANT SAFETY INFORMATION

  • MIEBO should not be administered while wearing contact lenses. Contact lenses should be removed before use and for at least 30 minutes after administration of MIEBO
  • Instruct patients to instill one drop of MIEBO into each eye four times daily
  • The safety and efficacy in pediatric patients below the age of 18 have not been established
  • The most common ocular adverse reaction was blurred vision (1% to 3% of patients reported blurred vision and conjunctival redness)

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Click here for full prescribing Information for MIEBO.